About
Dr. Benoit Samson is a highly skilled Medical Oncologist and Hematologist, offering expert care in the diagnosis and systemic treatment of both solid tumors and hematologic malignancies. Practicing at Hôpital Charles-Le Moyne, CICM - Hématologie-oncologie in Greenfield Park, QC, he is an integral part of a dedicated healthcare team committed to providing comprehensive oncology and blood disorder management. His practice adheres to the standards set by the Collège des médecins du Québec (CMQ), ensuring that patients receive care grounded in the latest clinical guidelines and ethical practices. Dr. Samson's focus is on delivering personalized treatment strategies that address each patient's unique medical condition and needs, utilizing advanced diagnostic tools and therapeutic options.
He graduated with a Medical Degree in 1983 and has been practicing as a Medical Oncologist and Hematologist for over 41 years. Throughout his extensive career, Dr. Samson completed comprehensive postgraduate training and attained certification in Medical Oncology and Hematology, specializing in cancer care and blood disorder treatment. His experience encompasses a wide spectrum of hematologic and oncologic conditions, emphasizing evidence-based approaches and multidisciplinary collaboration to optimize patient outcomes.
Dr. Samson is dedicated to providing compassionate, patient-centered care in Greenfield Park. He believes in a multidisciplinary approach that involves patients and their families in decision-making processes. His clinical philosophy centers on advancing research and integrating innovative therapies to improve quality of life and survival outcomes. Fluent in French, he ensures clear communication and empathetic support for his diverse patient population, committed to guiding them through complex treatment journeys with professionalism and kindness.
Dr. Benoit Samson has expertise in managing a wide range of conditions, including:
Hematologic Malignancies (Blood Cancers) Treated
- Myelodysplastic Syndromes (MDS): A group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy, mature blood cells.
- Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): A group of chronic blood cancers where the bone marrow produces too many red blood cells, white blood cells, or platelets.
- Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): A type of cancer that starts from white blood cells (lymphocytes) in the bone marrow, typically slow-growing.
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Vitamin B12 & Folate Deficiency Anemias: Anemias resulting from a lack of vitamin B12 or folate, essential for red blood cell formation.
- Aplastic Anemia & Bone Marrow Failure Syndromes: Rare but serious conditions where the bone marrow doesn't produce enough new blood cells.
- Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
Common Cancers (Solid Tumors) Treated
- Prostate Cancer: Cancer developing in the prostate gland in men, with treatment options including hormone therapy, chemotherapy, radiation, or active surveillance.
- Gastrointestinal Cancers (Esophageal, Stomach, Pancreatic, Liver, Biliary): A group of cancers affecting the digestive system organs, each requiring specific diagnostic and multidisciplinary treatment approaches including systemic therapies.
- Lung Cancer (Non-Small Cell & Small Cell): Cancers originating in the lungs, treated with chemotherapy, targeted therapy, immunotherapy, and/or radiation based on type and stage.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Benoit Samson or your referring physician.
- Adjuvant, Neoadjuvant, & Metastatic/Palliative Systemic Therapy: Developing treatment plans given before (neoadjuvant) or after (adjuvant) primary local treatment (like surgery or radiation) to improve outcomes, or for managing advanced/metastatic cancer to control disease and improve quality oflife.
- Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
- Management of Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): Treatment strategies to control blood counts, manage symptoms, and prevent complications associated with these chronic bone marrow disorders.
- Neutropenia & Other White Blood Cell Disorders Evaluation: Investigating and managing low or abnormal white blood cell counts, increasing susceptibility to infections.
- Management of Treatment-Related Side Effects & Toxicities: Proactive and reactive strategies to manage side effects of cancer therapies, including nausea, fatigue, myelosuppression, and neuropathy.
- Management of Clotting Disorders / Thrombophilia (Inherited & Acquired): Diagnosis, anticoagulation therapy, and long-term management for conditions predisposing to abnormal blood clots (e.g., DVT, PE, Factor V Leiden, Antiphospholipid Syndrome).
- Blood Product Transfusion Support & Management of Transfusion Reactions: Overseeing transfusions of red blood cells, platelets, plasma, and managing any adverse reactions.
Note: This list provides a general overview of services offered in Medical Oncology and Hematology (Cancer and Blood Disorders). Treatment plans are highly individualized. Dr. Samson provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Samson or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Benoit Samson practices primarily at the Hôpital Charles-Le Moyne, CICM - Hématologie-oncologie, situated in the areas near central Greenfield Park. The facility is conveniently located close to local points of interest, making it easily accessible for patients. It is well-served by local public transit options, allowing for convenient travel without the need for private vehicles. The hospital premises are wheelchair accessible, ensuring barrier-free access for all patients. Paid parking options are available nearby, providing ample parking space for visitors. The surrounding neighborhood offers a welcoming environment for patients and their families seeking comprehensive cancer and blood disorder care in a comfortable setting.
- Are consultations and treatments with Dr. Samson, an Medical Oncologist and Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Medical Oncologist and Hematologist such as Dr. Samson are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Samson's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Samson, an Medical Oncologist and Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Medical Oncologist and Hematologist like Dr. Samson for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- How will treatment decisions be made for my condition by Dr. Samson?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Samson will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
- What can I expect at my first appointment with an Oncologist/Hematologist?
- Your first appointment with Dr. Samson will be comprehensive and may last an hour or more. It will involve a detailed review of your medical history, family history of cancer, current symptoms, medications, and any previous tests, imaging results (CT, MRI, PET scans), and biopsy reports related to your diagnosis. He will likely perform a thorough physical examination. The main goals are to confirm your diagnosis, discuss the type and stage of your condition (if applicable), and outline potential treatment options. This is a crucial time to ask questions, and you are encouraged to bring a family member or friend for support and to help take notes. Dr. Samson will explain the proposed treatment plan, including goals, benefits, potential side effects, duration, and what to expect moving forward. Further tests may be ordered.
- How does cancer or blood disorder treatment differ for children compared to adults?
- As a Pediatric Hematologist/Oncologist, Dr. Samson specializes in these differences. Children's bodies react differently to treatments, and the types of cancers and blood disorders are often distinct from adult conditions. Treatment protocols are specifically designed for pediatric patients, considering their growth and development. Care is family-centered, involving parents and caregivers closely in decision-making and support.
- What kind of supportive care is available during cancer or hematology treatment with Dr. Samson?
- Supportive care is a crucial part of treatment, aiming to manage symptoms, reduce side effects, improve quality of life, and address emotional and practical needs. This can include effective pain and symptom management, nutritional support and counseling, psychological support (counseling, therapy), social work services for practical and emotional support, physiotherapy or occupational therapy, access to patient support groups, and spiritual care. Dr. Samson and the healthcare team at affiliated hospitals or cancer centres can connect you with these valuable resources.
Hôpital Charles-Le Moyne, CICM - Hématologie-oncologie
3120 boul Taschereau
Greenfield Park, QC J4V 2H1
Phone: (450) 466-5000 | Fax: (450) 466-5066
The facility is wheelchair accessible.
Dr. Samson is a licensed Medical Oncologist and Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=83365